Can one laser read thousands of biomarkers? Why ‘Theranos 2.0’ needs proof

A new documentary revisits Theranos, and with it a new startup: Haemanthus, founded by Elizabeth Holmes's partner, says its laser-based "AI-native" sensors can read thousands of biomarkers in blood, saliva and urine. Writing for McGill's Office for Science and Society, Sophie Tseng Pellar checks the science. Its patent describes a Raman spectroscopy instrument, not proof that it diagnoses anything, and no clinical data is public.
The physics is the harder part. Raman methods typically detect molecules in the millimolar range, while hormones such as cortisol circulate thousands of times more dilute. AI cannot recover a signal the instrument never picked up. For freethinkers, it is a reminder to ask for evidence before believing a pitch.
Source: Sophie Tseng Pellar, McGill Office for Science and Society (2026-11-20)
https://www.mcgill.ca/oss/article/student-contributors/theranos-20-raises-some-familiar-questions
Summarised by the FTI newsdesk.